BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

First published online November 22, 2006
British Journal of Radiology (2007) 80, 274-278
© 2007 British Institute of Radiology
doi: 10.1259/bjr/28164599

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuczer, D
Right arrow Articles by Plotkin, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuczer, D
Right arrow Articles by Plotkin, M

Short communication

123I-IMT SPECT for evaluation of the response to radiation therapy in high grade gliomas: a feasibility study

D Kuczer, MD2, A Feußner , MD2, R Wurm, MD2, P Wust, PhD2, R Michel, PhD2, F Stockhammer3, T Denecke, MD1, H Amthauer, MD1, R Felix, MD, PhD1 and M Plotkin, MD1

1 Department of Radiology, Nuclear Medicine and Radiooncology, Campus Virchow-Klinikum, 2 Department of Radiation Therapy, Campus Mitte, 3 Department of Neurosurgery, Campus Virchow-Klinikum, University Clinic Charité, Berlin, Germany

Correspondence: Dr Michail Plotkin, Senior Physician, Klinik für Strahlenheilkunde, Universitätsklinik Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany. E-mail: michail.plotkin{at}charite.de

Assessing response to radiation therapy in patients with high grade gliomas is needed upon making decisions toward further therapy strategies. Currently used standard imaging tools such as CT and MRI are not sensitive enough to detect early therapy effects. We prospectively investigated if single photon emission computed tomography (SPECT) using radiolabelled amino acid derivate 123I-methyltyrosine (IMT) would be useful for this aim. 10 patients with histologically proven high grade gliomas, who were candidates for radiation therapy, were enrolled in this investigation. All patients were examined by IMT SPECT before radiation therapy and 4 weeks after the initiation of the hypofractionated application of 40 Gy. Patients were followed up for 39 months; the tumours to background ratios (T/B) for IMT under/before radiation therapy were correlated to survival times. Initially, SPECT depicted an abnormal intratumoural IMT uptake in all patients (mean T/B ratios 1.37–1.87). In four out of 10 patients, the mean T/B ratios decreased by more than 10% under radiation therapy. In six other patients, the BQ decreased by less than 10% or increased. There were no significant correlations between the degree of changes in T/B and survival (r = –0.1, p = 0.973). Serial IMT SPECT measurements allow detection of changes in amino acid accumulation in high-grade gliomas under radiation therapy. However, these changes seem to possess no prognostic value in respect to survival prediction.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2007 by the British Institute of Radiology.